These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7797343)
1. Combined oral contraceptives and risk of cervical carcinoma in situ. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Ye Z; Thomas DB; Ray RM Int J Epidemiol; 1995 Feb; 24(1):19-26. PubMed ID: 7797343 [TBL] [Abstract][Full Text] [Related]
2. Invasive cervical cancer and combined oral contraceptives. WHO collaborative study of neoplasia and steroid contraceptives. Br Med J (Clin Res Ed); 1985 Mar; 290(6473):961-5. PubMed ID: 3919869 [TBL] [Abstract][Full Text] [Related]
3. Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Thomas DB; Ye Z; Ray RM Contraception; 1995 Jan; 51(1):25-31. PubMed ID: 7750280 [TBL] [Abstract][Full Text] [Related]
4. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer; 1993 Sep; 55(2):228-36. PubMed ID: 8370621 [TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives and cervical carcinoma in situ in Chile. Molina R; Thomas DB; Dabancens A; Lopez J; Ray RM; Martinez L; Salas O Cancer Res; 1988 Feb; 48(4):1011-5. PubMed ID: 3338072 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer and combined oral contraceptives: results from a multinational study. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Br J Cancer; 1990 Jan; 61(1):110-9. PubMed ID: 2404507 [TBL] [Abstract][Full Text] [Related]
7. Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia. La Vecchia C Contraception; 1994 Mar; 49(3):223-30. PubMed ID: 8200216 [TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives and breast cancer risk among younger women. Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232 [TBL] [Abstract][Full Text] [Related]
9. Influence of oral contraceptives on the incidence of premalignant and malignant lesions of the cervix. Andolśek L; Kovaćic J; Koźuh M; Litt B Contraception; 1983 Dec; 28(6):505-19. PubMed ID: 6673904 [TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Thomas DB; Ray RM Am J Epidemiol; 1996 Aug; 144(3):281-9. PubMed ID: 8686697 [TBL] [Abstract][Full Text] [Related]
11. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Moreno V; Bosch FX; Muñoz N; Meijer CJ; Shah KV; Walboomers JM; Herrero R; Franceschi S; Lancet; 2002 Mar; 359(9312):1085-92. PubMed ID: 11943255 [TBL] [Abstract][Full Text] [Related]
12. Monthly injectable steroid contraceptives and cervical carcinoma. Thomas DB; Molina R; Rodriguez Cuevas H; Ray RM; Riotton G; Dabancens A; Benavides S; Martinez L; Salas O; Pallet JA Am J Epidemiol; 1989 Aug; 130(2):237-47. PubMed ID: 2665476 [TBL] [Abstract][Full Text] [Related]
13. Epithelial ovarian cancer and combined oral contraceptives. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol; 1989 Sep; 18(3):538-45. PubMed ID: 2807655 [TBL] [Abstract][Full Text] [Related]
14. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: the influence of combined oral contraceptives on risk of neoplasms in developing and developed countries. Thomas DB Contraception; 1991 Jun; 43(6):695-710. PubMed ID: 1868738 [TBL] [Abstract][Full Text] [Related]
15. Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use. Kjaer SK; Engholm G; Dahl C; Bock JE; Lynge E; Jensen OM Cancer Causes Control; 1993 Nov; 4(6):513-9. PubMed ID: 8280828 [TBL] [Abstract][Full Text] [Related]
16. A review of problems of bias and confounding in epidemiologic studies of cervical neoplasia and oral contraceptive use. Swan SH; Petitti DB Am J Epidemiol; 1982 Jan; 115(1):10-8. PubMed ID: 7034529 [TBL] [Abstract][Full Text] [Related]
17. Cervical adenocarcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Jones MW; Silverberg SG Obstet Gynecol; 1989 Jun; 73(6):984-9. PubMed ID: 2726119 [TBL] [Abstract][Full Text] [Related]
18. Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study. La Vecchia C; Decarli A; Fasoli M; Franceschi S; Gentile A; Negri E; Parazzini F; Tognoni G Br J Cancer; 1986 Aug; 54(2):311-7. PubMed ID: 3741766 [TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives and cervical cancer risk in Costa Rica. Detection bias or causal association? Irwin KL; Rosero-Bixby L; Oberle MW; Lee NC; Whatley AS; Fortney JA; Bonhomme MG JAMA; 1988 Jan; 259(1):59-64. PubMed ID: 3334773 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer among young U.S. women in relation to oral contraceptive use. White E; Malone KE; Weiss NS; Daling JR J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]